These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 318916)
1. A phase III study comparing the clinical utility of four regimens of 5-fluorouracil: a preliminary report. Ansfield F; Klotz J; Nealon T; Ramirez G; Minton J; Hill G; Wilson W; Davis H; Cornell G Cancer; 1977 Jan; 39(1):34-40. PubMed ID: 318916 [TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy in cancer of the colon and rectum: demonstration of effectiveness of prolonged 5-FU chemotherapy in a prospectively controlled, randomized trial. Grage TB; Moss SE Surg Clin North Am; 1981 Dec; 61(6):1321-9. PubMed ID: 6171898 [No Abstract] [Full Text] [Related]
3. Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer. Sugarbaker PH; Gianola FJ; Speyer JC; Wesley R; Barofsky I; Meyers CE Surgery; 1985 Sep; 98(3):414-22. PubMed ID: 3898450 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy as an adjuvant to surgery for colorectal cancer. A follow-up report. Lawrence W; Terz JJ; Horsley JS; Brown PW; Romero C Arch Surg; 1978 Feb; 113(2):164-8. PubMed ID: 343748 [TBL] [Abstract][Full Text] [Related]
5. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. Petrelli N; Herrera L; Rustum Y; Burke P; Creaven P; Stulc J; Emrich LJ; Mittelman A J Clin Oncol; 1987 Oct; 5(10):1559-65. PubMed ID: 2443619 [TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278). Engstrom PF; MacIntyre JM; Mittelman A; Klaassen DJ Am J Clin Oncol; 1984 Aug; 7(4):313-8. PubMed ID: 6377866 [TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association. Richards F; Case LD; White DR; Muss HB; Spurr CL; Jackson DV; Cooper MR; Zekan P; Cruz J; Stuart JJ J Clin Oncol; 1986 Apr; 4(4):565-70. PubMed ID: 3514806 [TBL] [Abstract][Full Text] [Related]
8. Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)-1(2-chlorethyl)-1-nitrosourea: a Phase II-III study of the Eastern Cooperative Oncology Group (EST 4273). Douglass HO; Lavin PT; Woll J; Conroy JF; Carbone P Cancer; 1978 Dec; 42(6):2538-45. PubMed ID: 365312 [TBL] [Abstract][Full Text] [Related]
9. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM; Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829 [TBL] [Abstract][Full Text] [Related]
10. Comparison of oral ftorafur and intravenous 5-fluorouracil in patients with advanced cancer of the stomach, colon or rectum. Bjerkeset T; Fjøsne HE Oncology; 1986; 43(4):212-5. PubMed ID: 3088506 [TBL] [Abstract][Full Text] [Related]
11. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. Erlichman C; Fine S; Wong A; Elhakim T J Clin Oncol; 1988 Mar; 6(3):469-75. PubMed ID: 3280741 [TBL] [Abstract][Full Text] [Related]
12. A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon. Czito BG; Hong TJ; Cohen DP; Tyler DS; Lee CG; Anscher MS; Ludwig KA; Seigler HF; Mantyh C; Morse MA; Lockhart AC; Petros WP; Honeycutt W; Spector NL; Ertel PJ; Mangum SG; Hurwitz HI Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):779-85. PubMed ID: 14967434 [TBL] [Abstract][Full Text] [Related]
13. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study. Lokich JJ; Ahlgren JD; Gullo JJ; Philips JA; Fryer JG J Clin Oncol; 1989 Apr; 7(4):425-32. PubMed ID: 2926468 [TBL] [Abstract][Full Text] [Related]
14. Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges. Lokich JJ; Moore CL; Anderson NR Cancer; 1996 Jul; 78(2):294-9. PubMed ID: 8674006 [TBL] [Abstract][Full Text] [Related]
15. A prospective randomized trial of fluorouracil versus fluorouracil plus cisplatin in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group trial. Loehrer PJ; Turner S; Kubilis P; Hui S; Correa J; Ansari R; Stephens D; Woodburn R; Meyer S J Clin Oncol; 1988 Apr; 6(4):642-8. PubMed ID: 3282033 [TBL] [Abstract][Full Text] [Related]
16. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan. Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054 [TBL] [Abstract][Full Text] [Related]
17. Oral ftorafur versus intravenous 5-fluorouracil. A comparative study in patients with colorectal cancer. Andersen E; Pedersen H Acta Oncol; 1987; 26(6):433-6. PubMed ID: 3128309 [TBL] [Abstract][Full Text] [Related]
18. Results of a randomized trial with or without 5-FU-based preoperative chemotherapy followed by postoperative chemotherapy in resected colon and rectal carcinoma. Colorectal Cancer Chemotherapy Study Group of Japan - The 2nd Trial Jpn J Clin Oncol; 2003 Jun; 33(6):288-96. PubMed ID: 12913083 [TBL] [Abstract][Full Text] [Related]
19. Phase II study of sequential methotrexate-5-FU therapy in advanced measurable colorectal cancer. Cantrell JE; Brunet R; Lagarde C; Schein PS; Smith FP Cancer Treat Rep; 1982 Jul; 66(7):1563-5. PubMed ID: 7093972 [TBL] [Abstract][Full Text] [Related]
20. Sequential methotrexate and 5-FU in the treatment of colorectal cancer. Weinerman B; Schacter B; Schipper H; Bowman D; Levitt M Cancer Treat Rep; 1982 Jul; 66(7):1553-5. PubMed ID: 6980048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]